Kengo Azushima

2.2k total citations
94 papers, 1.5k citations indexed

About

Kengo Azushima is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Kengo Azushima has authored 94 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cardiology and Cardiovascular Medicine, 34 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Molecular Biology. Recurrent topics in Kengo Azushima's work include Hormonal Regulation and Hypertension (23 papers), Renin-Angiotensin System Studies (23 papers) and Blood Pressure and Hypertension Studies (19 papers). Kengo Azushima is often cited by papers focused on Hormonal Regulation and Hypertension (23 papers), Renin-Angiotensin System Studies (23 papers) and Blood Pressure and Hypertension Studies (19 papers). Kengo Azushima collaborates with scholars based in Japan, Singapore and United States. Kengo Azushima's co-authors include Kouichi Tamura, Hiromichi Wakui, Thomas M. Coffman, Susan B. Gurley, Kazushi Uneda, Tomohiko Kanaoka, Satoshi Umemura, Akio Yamashita, Sho Kinguchi and Masato Ohsawa and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Kengo Azushima

88 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kengo Azushima Japan	21	503	492	390	320	226	94	1.5k
Hiromichi Wakui Japan	26	816 1.6×	583 1.2×	470 1.2×	339 1.1×	278 1.2×	125	1.9k
Isabelle Chénier Canada	25	371 0.7×	368 0.7×	692 1.8×	293 0.9×	151 0.7×	47	1.5k
Kum Hyun Han South Korea	27	336 0.7×	376 0.8×	545 1.4×	557 1.7×	315 1.4×	50	2.0k
Shawna A. Cooper United States	16	385 0.8×	346 0.7×	432 1.1×	122 0.4×	235 1.0×	22	1.3k
Jérémy Bellien France	23	630 1.3×	349 0.7×	388 1.0×	224 0.7×	241 1.1×	76	1.9k
Christiane Rüster Germany	13	244 0.5×	320 0.7×	313 0.8×	495 1.5×	128 0.6×	21	1.3k
Laine J. Murphey United States	24	494 1.0×	359 0.7×	325 0.8×	186 0.6×	176 0.8×	38	1.8k
Masahito Imanishi Japan	24	487 1.0×	287 0.6×	258 0.7×	328 1.0×	152 0.7×	73	1.4k
Akemi Katsurada United States	21	910 1.8×	788 1.6×	294 0.8×	288 0.9×	176 0.8×	36	1.4k
Tomio Onuma Japan	24	425 0.8×	778 1.6×	288 0.7×	138 0.4×	260 1.2×	53	1.4k

Countries citing papers authored by Kengo Azushima

Since Specialization

Citations

This map shows the geographic impact of Kengo Azushima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kengo Azushima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kengo Azushima more than expected).

Fields of papers citing papers by Kengo Azushima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kengo Azushima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kengo Azushima. The network helps show where Kengo Azushima may publish in the future.

Co-authorship network of co-authors of Kengo Azushima

This figure shows the co-authorship network connecting the top 25 collaborators of Kengo Azushima. A scholar is included among the top collaborators of Kengo Azushima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kengo Azushima. Kengo Azushima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akasaki, Yuichi, Yasunori Suematsu, Kengo Azushima, et al.. (2025). Impact of patient care teams on blood pressure control in patients with hypertension: a systematic review and meta-analysis. Hypertension Research. 48(6). 1827–1838. 3 indexed citations

Azushima, Kengo, Kento Kitada, Kazuya Nakagawa, et al.. (2025). Keratinocyte-specific angiotensin II receptor-associated protein deficiency exacerbates angiotensin II-dependent hypertension via activation of the skin renin-angiotensin system. Nature Communications. 16(1). 4789–4789.

Azushima, Kengo, et al.. (2025). Leucine-rich alpha-2-glycoprotein 1 deficiency suppresses ischemia–reperfusion injury-induced renal fibrosis. Scientific Reports. 15(1). 1259–1259. 1 indexed citations

Wakui, Hiromichi, Yuki Kawai, Ryu Kobayashi, et al.. (2024). Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study. Journal of Atherosclerosis and Thrombosis. 31(10). 1370–1385. 2 indexed citations

Tanaka, Shohei, Hiromichi Wakui, Kengo Azushima, et al.. (2023). Effects of a High-Protein Diet on Kidney Injury under Conditions of Non-CKD or CKD in Mice. International Journal of Molecular Sciences. 24(9). 7778–7778. 9 indexed citations

Azushima, Kengo, Takahiro Yamaji, Toru Suzuki, et al.. (2023). Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain. Hypertension Research. 47(1). 55–66. 6 indexed citations

Tsukamoto, Shunichiro, Takayuki Yamada, Kazushi Uneda, et al.. (2023). Effects of sodium‐glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients. Diabetes Obesity and Metabolism. 25(5). 1271–1279. 7 indexed citations

Tsukamoto, Shunichiro, Hiromichi Wakui, Kengo Azushima, et al.. (2023). Combination of sacubitril/valsartan and blockade of the PI3K pathway enhanced kidney protection in a mouse model of cardiorenal syndrome. European Heart Journal Open. 3(6). oead098–oead098. 2 indexed citations

Tsukamoto, Shunichiro, Shohei Tanaka, Takayuki Yamada, et al.. (2023). Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon‐like peptide‐1 receptor agonists in Japanese patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 26(1). 262–274. 13 indexed citations

10.

Abe, Eriko, Akio Yamashita, Takahiro Yamaji, et al.. (2022). Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization. Scientific Reports. 12(1). 17376–17376. 4 indexed citations

11.

Wakui, Hiromichi, Kengo Azushima, Sho Kinguchi, et al.. (2022). SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan. Clinical and Experimental Nephrology. 26(10). 988–996. 7 indexed citations

12.

Tsukamoto, Shunichiro, Takayuki Yamada, Kengo Azushima, et al.. (2021). Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis. Clinical Rheumatology. 41(3). 911–919. 29 indexed citations

13.

Urate, Shingo, Hiromichi Wakui, Kengo Azushima, et al.. (2021). Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice. International Journal of Molecular Sciences. 22(22). 12432–12432. 22 indexed citations

14.

Ishigami, Tomoaki, Toshihiro Nanki, Kôtarô Uchida, et al.. (2021). Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis. Methods and Protocols. 4(4). 83–83. 3 indexed citations

15.

Uchida, Kôtarô, Michiko Sugiyama, Kengo Azushima, et al.. (2021). Blood Pressure Elevation of Tubular Specific (P)RR Transgenic Mice and Lethal Tubular Degeneration due to Possible Intracellular Interactions between (P)RR and Alternative Renin Products. International Journal of Molecular Sciences. 23(1). 302–302. 8 indexed citations

16.

Kawai, Yuki, Yoshiyuki Toya, Hiromichi Wakui, et al.. (2021). Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial. Journal of Clinical Hypertension. 23(4). 870–878. 2 indexed citations

17.

Azushima, Kengo, et al.. (2020). Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors. Current Hypertension Reports. 22(3). 22–22. 53 indexed citations

18.

Haku, Sona, Hiromichi Wakui, Kengo Azushima, et al.. (2018). Early Enhanced Leucine-Rich α-2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice. BioMed Research International. 2018. 1–9. 24 indexed citations

19.

Tamura, Kouichi, Hiromichi Wakui, Kengo Azushima, Kazushi Uneda, & Satoshi Umemura. (2016). Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes. Hypertension Research. 39(6). 396–398. 16 indexed citations

20.

Tamura, Kouichi, Mai Yanagi, Tetsuya Fujikawa, et al.. (2012). 755 EFFECTS OF OLMESARTAN ON AMBULATORY BLOOD PRESSURE AND RENAL FUNCTION IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE. Journal of Hypertension. 30(Supplement 1). e218–e218.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact